Mancia et al. (2020) conducted a case-control study in the Lombardy...

Question

# Mancia et al. (2020) conducted a case-control study in the Lombardy...

Mancia et al. (2020) conducted a case-control study in the Lombardy region of Italy to examine the association between the use of angiotensin-converting-enzyme (ACE) inhibitors and the odds of coronavirus disease 2019 (COVID-19). There were 1,502 COVID-19 cases among the 8,071 patients who used ACE inhibitors. There were 4,770 COVID-19 cases among the 28,960 patients who did not use ACE inhibitors. Using a 0.05 significance level, you need to test the claim that the proportion of COVID-19 patients among those who used ACE inhibitors (group 1) is higher than the proportion of COVID-19 patients among those who did not use ACE inhibitors (group 2).

What proportion of ACE inhibitor users were not COVID-19 cases? (0.5 points)

Select one:

a. 0.14

b. 0.16

c. 0.19

d. 0.81

e. 0.84

Solved by verified expert

sectetu

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit

sec

10,000 step-by-step explanations

<p><strong>sectetu</strong></p><p> </p><p> </p><p>sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit</p>sec

## Step-by-step explanation

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus eff

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellente

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitsectetu

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, di

sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit